Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Operating Expenses (2016 - 2025)

Jaguar Health (JAGX) has disclosed Operating Expenses for 11 consecutive years, with $10.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Expenses changed 0.47% to $10.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $44.6 million, a 9.57% increase, with the full-year FY2024 number at $42.5 million, down 3.48% from a year prior.
  • Operating Expenses was $10.3 million for Q3 2025 at Jaguar Health, down from $11.0 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $14.4 million in Q1 2022 to a low of $9.4 million in Q2 2022.
  • A 5-year average of $11.1 million and a median of $10.8 million in 2023 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: soared 66.74% in 2021, then decreased 26.06% in 2022.
  • Jaguar Health's Operating Expenses stood at $12.9 million in 2021, then decreased by 26.06% to $9.5 million in 2022, then grew by 3.26% to $9.9 million in 2023, then grew by 18.35% to $11.7 million in 2024, then fell by 11.53% to $10.3 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Operating Expenses are $10.3 million (Q3 2025), $11.0 million (Q2 2025), and $11.6 million (Q1 2025).